RCEL241220P2500
- 0.00
- 0.000.00%
Avita Medical Newsroom
AVITA Medical to Present at the Piper Sandler 36th Annual Healthcare Conference
Express News | AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
Avita Medical's Total Revenue Climbs 44% in Q3; Net Loss Widens
Avita Medical Target Price Raised 28% to A$4.60/Share by Bell Potter>AVH.AU
AVITA Medical, Inc. (RCEL) Q3 2024 Earnings Call Transcript
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Cuts Target Price to $20
AVITA Medical to Host Investor Webinar Briefing
Piper Sandler Reiterates Neutral on AVITA Medical, Raises Price Target to $12
AVITA Medical Analyst Ratings
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
Avita Medical: Strong Buy Rating Backed by Record Sales and Promising Growth Prospects
Avita Medical Shares Are Trading Higher After the Company Issued Q4 Revenue Guidance Above Estimates.
Express News | Corrected-AVITA Medical Inc - Q3 Commercial Revenue of $19.5 Mln (Corrects Currency to USD)
Express News | AVITA Medical Inc - Qtrly Shr Loss $0.62
Express News | AVITA Medical Inc - Commercial Revenue for 2024 Is Expected to Be Within Previously Provided Revenue Guidance of $68.0 to $70.0 Mln
10-Q: Q3 2024 Earnings Report
8-K: AVITA Medical Reports Third Quarter Financial Results
Express News | AVITA Medical Q3 Operating Expenses USD 30.2 Million
Here Are the Major Earnings After the Close Today
Earnings Preview: RCEL to Report Financial Results Post-market on November 07
$Avita Medical(RCEL.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $Avita Medical(RCEL.US)$ to post revenue of USD20.21M for 2024Q3